AlphaGrep UK Ltd’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.62M Buy
7,649
+1,291
+20% +$278K 0.47% 8
2025
Q4
$1.31M Buy
+6,358
New +$1.2M 0.44% 12

Other funds holding CAH

AlphaGrep UK Ltd's CAH Position: Q1 2026 in Review

AlphaGrep UK Ltd increased its Cardinal Health (CAH) stake by 20% in Q1 2026, buying an estimated $278K and bringing the position to 7,649 shares worth $1.62M. The position accounts for 0.47% of the portfolio, ranked #8.

AlphaGrep UK Ltd first reported a position in CAH in Q4 2025 and has held it in 2 quarters since. 1,432 funds tracked by Wall St. Rank hold CAH as of Q1 2026.

  • AlphaGrep UK Ltd held 7,649 shares of Cardinal Health worth $1.62M as of Q1 2026.
  • AlphaGrep UK Ltd bought 1,291 Cardinal Health shares in Q1 2026, an estimated $278K.
  • Cardinal Health made up 0.47% of AlphaGrep UK Ltd's portfolio in Q1 2026, its #8 holding.
  • AlphaGrep UK Ltd first reported a position in Cardinal Health in Q4 2025 and has held it in 2 quarters since.
  • 1,432 funds tracked by Wall St. Rank held Cardinal Health as of Q1 2026.

Based on AlphaGrep UK Ltd's 13F filing for Q1 2026, filed 13 Aug 2026.